Glenmede Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.6M | Buy |
48,182
+1,654
| +4% | +$613K | 0.08% | 208 |
|
|
2026
Q1 | $13.6M | Buy |
46,528
+7,234
| +18% | +$2.38M | 0.07% | 252 |
|
|
2025
Q4 | $13.8M | Buy |
+39,294
| New | +$13.3M | 0.07% | 260 |
|
|
2025
Q1 | $13.3M | Sell |
30,464
-30,061
| -50% | -$12.1M | 0.07% | 280 |
|
|
2024
Q4 | $22.3M | Sell |
60,525
-30,175
| -33% | -$12.6M | 0.11% | 168 |
|
|
2024
Q3 | $47.2M | Sell |
90,700
-36,028
| -28% | -$19.2M | 0.23% | 94 |
|
|
2024
Q2 | $68.7M | Sell |
126,728
-8,125
| -6% | -$4.29M | 0.35% | 72 |
|
|
2024
Q1 | $69.9M | Sell |
134,853
-24,851
| -16% | -$12.4M | 0.35% | 70 |
|
|
2023
Q4 | $75.3M | Buy |
159,704
+16,475
| +12% | +$7.62M | 0.39% | 60 |
|
|
2023
Q3 | $62.4M | Sell |
143,229
-2,040
| -1% | -$925K | 0.36% | 71 |
|
|
2023
Q2 | $66.8M | Sell |
145,269
-66
| -0% | -$30.4K | 0.38% | 71 |
|
|
2023
Q1 | $66.8M | Buy |
145,335
+3,221
| +2% | +$1.53M | 0.38% | 71 |
|
|
2022
Q4 | $72.9M | Sell |
142,114
-5,945
| -4% | -$3.02M | 0.43% | 61 |
|
|
2022
Q3 | $67.3M | Buy |
148,059
+75,150
| +103% | +$36M | 0.42% | 59 |
|
|
2022
Q2 | $35.2M | Buy |
72,909
+1,140
| +2% | +$564K | 0.21% | 112 |
|
|
2022
Q1 | $35.3M | Buy |
71,769
+7,776
| +12% | +$3.55M | 0.17% | 138 |
|
|
2021
Q4 | $29.7M | Buy |
63,993
+5,224
| +9% | +$2.2M | 0.14% | 167 |
|
|
2021
Q3 | $21.9M | Buy |
58,769
+4,591
| +8% | +$1.74M | 0.11% | 205 |
|
|
2021
Q2 | $20.7M | Buy |
54,178
+105
| +0.2% | +$40.1K | 0.11% | 215 |
|
|
2021
Q1 | $19.4M | Sell |
54,073
-39,664
| -42% | -$12.8M | 0.1% | 223 |
|
|
2020
Q4 | $30.1M | Sell |
93,737
-1,292
| -1% | -$396K | 0.17% | 154 |
|
|
2020
Q3 | $25.5M | Sell |
95,029
-1,152
| -1% | -$310K | 0.15% | 161 |
|
|
2020
Q2 | $25.3M | Sell |
96,181
-62,846
| -40% | -$16.8M | 0.15% | 153 |
|
|
2020
Q1 | $48M | Hold |
159,027
| – | – | 0.22% | 129 |
|
|
2019
Q4 | $48M | Sell |
159,027
-25,954
| -14% | -$7.14M | 0.22% | 129 |
|
|
2019
Q3 | $44.4M | Sell |
184,981
-20,266
| -10% | -$5.55M | 0.2% | 133 |
|
|
2019
Q2 | $57.9M | Sell |
205,247
-3,639
| -2% | -$994K | 0.25% | 108 |
|
|
2019
Q1 | $59.9M | Sell |
208,886
-6,151
| -3% | -$1.78M | 0.27% | 98 |
|
|
2018
Q4 | $56.5M | Sell |
215,037
-8,494
| -4% | -$2.34M | 0.28% | 96 |
|
|
2018
Q3 | $61.3M | Sell |
223,531
-27,311
| -11% | -$7.09M | 0.25% | 103 |
|
|
2018
Q2 | $59.7M | Buy |
250,842
+65
| +0% | +$15.1K | 0.26% | 95 |
|
|
2018
Q1 | $56.4M | Hold |
250,777
| – | – | 0.24% | 109 |
|
|
2017
Q4 | $56.4M | Sell |
250,777
-7,855
| -3% | -$1.67M | 0.24% | 109 |
|
|
2017
Q3 | $49.1M | Sell |
258,632
-104,648
| -29% | -$19.9M | 0.22% | 135 |
|
|
2017
Q2 | $60.1M | Hold |
363,280
| – | – | 0.29% | 89 |
|
|
2017
Q1 | $60.1M | Buy |
363,280
+110,985
| +44% | +$17.7M | 0.29% | 89 |
|
|
2016
Q4 | $36.3M | Buy |
252,295
+1,112
| +0.4% | +$149K | 0.2% | 173 |
|
|
2016
Q3 | $31.5M | Buy |
251,183
+89,095
| +55% | +$11.5M | 0.18% | 194 |
|
|
2016
Q2 | $21.3M | Buy |
162,088
+18,056
| +13% | +$2.47M | 0.13% | 266 |
|
|
2016
Q1 | $20M | Sell |
144,032
-77,011
| -35% | -$10.3M | 0.13% | 259 |
|
|
2015
Q4 | $30.8M | Sell |
221,043
-13,684
| -6% | -$1.89M | 0.21% | 140 |
|
|
2015
Q3 | $32.9M | Buy |
234,727
+48,159
| +26% | +$7.24M | 0.24% | 117 |
|
|
2015
Q2 | $30.6M | Sell |
186,568
-9,524
| -5% | -$1.52M | 0.22% | 137 |
|
|
2015
Q1 | $30.3M | Sell |
196,092
-46,164
| -19% | -$6.57M | 0.22% | 127 |
|
|
2014
Q4 | $30.4M | Buy |
242,256
+29,600
| +14% | +$3.66M | 0.24% | 118 |
|
|
2014
Q3 | $25.4M | Buy |
212,656
+3,448
| +2% | +$395K | 0.22% | 113 |
|
|
2014
Q2 | $22.5M | Buy |
209,208
+23,342
| +13% | +$2.41M | 0.2% | 126 |
|
|
2014
Q1 | $18.5M | Buy |
185,866
+32,182
| +21% | +$2.91M | 0.17% | 153 |
|
|
2013
Q4 | $14.2M | Buy |
153,684
+17,701
| +13% | +$1.57M | 0.15% | 183 |
|
|
2013
Q3 | $11.4M | Buy |
135,983
+5,994
| +5% | +$514K | 0.14% | 193 |
|
|
2013
Q2 | $10.6M | Buy |
+129,989
| New | +$9.73M | 0.13% | 161 |
|
Other funds holding ELV
Glenmede Trust's ELV Position: Q2 2026 in Review
Glenmede Trust increased its Elevance Health (ELV) stake by 3.6% in Q2 2026, buying an estimated $613K and bringing the position to 48,182 shares worth $18.6M. The position accounts for 0.08% of the portfolio, ranked #208.
Glenmede Trust first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $75.3M in Q4 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Glenmede Trust held 48,182 shares of Elevance Health worth $18.6M as of Q2 2026.
- Glenmede Trust bought 1,654 Elevance Health shares in Q2 2026, an estimated $613K.
- Elevance Health made up 0.08% of Glenmede Trust's portfolio in Q2 2026, its #208 holding.
- Glenmede Trust first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
- Glenmede Trust's Elevance Health position peaked at $75.3M in Q4 2023.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.